Please login to the form below

Not currently logged in
Email:
Password:

Gemzar

This page shows the latest Gemzar news and features for those working in and with pharma, biotech and healthcare.

Shire wins EU licence for pancreatic cancer drug Onivyde

Shire wins EU licence for pancreatic cancer drug Onivyde

treatment with Lilly's Gemzar (gemcitabine). ... Celgene's Abraxane (paclitaxel) in combination with Gemzar.

Latest news

More from news
Approximately 2 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...
The 10-year Web Challenge
Understanding your users’ needs is more critical online today than ever. A site should mould itself around these insights, deliver those needs quickly, efficiently and with plenty of white space....
Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....

Infographics